We are live on ! Find out more
IPXL

Impax Laboratories, Inc.
IPXL

Delisted

IPXL was delisted on the 4th of May, 2018.

Back to rankings

149 hedge funds and large institutions have $1.12B invested in Impax Laboratories, Inc. in 2013 Q2 according to their latest regulatory filings, with 149 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

47% less call options, than puts

Call options by funds: $3.82M | Put options by funds: $7.28M

Holders
149
Holders Change
+149
Holders Change %
–
% of All Funds
4.86%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.1%
New
149
Increased
–
Reduced
–
Closed
–
Calls
$3.82M
Puts
$7.28M
Net Calls
-$3.46M
Net Calls Change
-$3.46M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$13.3M +$11.6M +653,969 New
JP Morgan Chase
27
JP Morgan Chase
New York
$12.9M +$11.5M +647,068 New
VOYA Investment Management
28
VOYA Investment Management
Georgia
$12.8M +$11.4M +640,151 New
TC
29
TFS Capital
Pennsylvania
$11.2M +$9.96M +560,974 New
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$8.94M +$7.96M +448,289 New
TCIM
31
TIAA CREF Investment Management
New York
$8.16M +$7.26M +409,074 New
Principal Financial Group
32
Principal Financial Group
Iowa
$7.25M +$6.45M +363,448 New
PAMU
33
Pictet Asset Management (UK)
United Kingdom
$7.16M +$6.37M +359,000 New
TCM
34
Tekla Capital Management
Massachusetts
$6.88M +$6.12M +344,683 New
Norges Bank
35
Norges Bank
Norway
$6.55M +$5.83M +328,524 New
TRSOTSOK
36
Teachers Retirement System of the State of Kentucky
Kentucky
$6.22M +$5.54M +312,100 New
BIM
37
BlackRock Investment Management
Delaware
$5.38M +$4.79M +269,881 New
Geode Capital Management
38
Geode Capital Management
Massachusetts
$5.36M +$4.76M +268,402 New
Bank of Montreal
39
Bank of Montreal
Ontario, Canada
$5.35M +$4.76M +268,139 New
Goldman Sachs
40
Goldman Sachs
New York
$5.29M +$4.71M +265,468 New
American Century Companies
41
American Century Companies
Missouri
$5.24M +$4.67M +262,838 New
TA
42
Teachers Advisors
New York
$5.19M +$4.62M +260,332 New
CII
43
CR Intrinsic Investors
Connecticut
$5.15M +$4.58M +258,000 New
PC
44
PointState Capital
New York
$4.99M +$4.44M +250,000 New
OAM
45
Oxford Asset Management
United Kingdom
$4.73M +$4.21M +237,032 New
CCMH
46
Cornerstone Capital Management Holdings
New York
$4.19M +$3.73M +209,965 New
Federated Hermes
47
Federated Hermes
Pennsylvania
$3.92M +$3.49M +196,627 New
Deutsche Bank
48
Deutsche Bank
Germany
$3.66M +$3.26M +183,805 New
KCM
49
Kingdon Capital Management
New York
$3.19M +$2.84M +160,000 New
AllianceBernstein
50
AllianceBernstein
Tennessee
$3.16M +$2.81M +158,185 New
1
2
3 4 5

IPXL Hedge Fund Activity: Q2 2013 in Review

149 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Impax Laboratories, Inc. (IPXL) for Q2 2013, worth a combined $1.12B.

Buyers outnumbered sellers: 149 funds opened new IPXL positions and 0 closed out — a net gain of 149 holders — while 0 added to existing stakes and 0 trimmed.

  • 149 institutional investors held Impax Laboratories, Inc. (IPXL) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.12B of Impax Laboratories, Inc. stock for Q2 2013.
  • 149 funds opened new Impax Laboratories, Inc. positions in Q2 2013 and 0 closed out, a net change of +149 holders.

Based on aggregated 13F filings for Q2 2013.